  | Gillet, A., van der Lande, G., Aubinet, C., Cardone, P., Nunez Novo, P., Alnagger, N., Annen, J., Bernard, C., Bicego, A. Y., Cecconi, B., Fritz, P., Gosseries, O., Grégoire, C., Hustinx, R., Lejeune, N., Louras, M., Maquet, N., Marie, N., Martens, G., ... Sala, A. (28 November 2025). A Protocol and Preliminary Insights for the Acquisition of a Multimodal Brain Dataset of Healthy Participants [Poster presentation]. GIGANeuro Day. |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., Bridoux, J., Navarro, L. (Other coll.), & Dumoulin, M. (Other coll.). (29 September 2025). Development of a Single-Domain Antibody-Based Radiopharmaceutical for Targeted Alpha Therapy of Multiple Myeloma [Poster presentation]. Single Domain Antibodies Conference 2025, Utrecht, Netherlands.  Editorial reviewed |
  | Kleiburg, F., Dirix, P., Fonteyne, V., Bral, S., De Troyer, B., Sautois, B., Lamande, M., Liefhooghe, N., Grisay, G., Meersschout, S., Vandermeulen, A., Jullian, N., Staelens, L., Poelaert, F., Strijbos, M., Verschueren, J., Goffin, K., Withofs, N., & Ost, P. (2025). Stage Migration on Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography in Comparison to Conventional Imaging in Patients with High-risk Prostate Cancer Referred for Radiation Therapy: Results from the Phase 2/3 THUNDER Trial. European Urology Oncology. doi:10.1016/j.euo.2025.08.005 Peer Reviewed verified by ORBi |
 | Gillet, A., PALMERI, D., Bernard, C., van der Lande, G., Aubinet, C., Cardone, P., Nunez Novo, P., Alnagger, N., Annen, J., Bicego, A. Y., Cecconi, B., Fritz, P., Gosseries, O., Grégoire, C., Lejeune, N., Louras, M., Maquet, N., Marie, N., Martens, G., ... Sala, A. (12 September 2025). A protocol for the construction of a multimodal brain dataset for healthy control subjects [Poster presentation]. GIGA DAY 2025, Liège, Belgium. Peer reviewed |
 | Denis, C., Cousin, F., De Laere, B., Vanwelkenhuyzen, J., Hustinx, R., Sautois, B.* , & Withofs, N.*. (02 September 2025). Assessing Interlesional Tumor Response and Patient Outcomes with Sequential PSMA PET/CT in Metastatic Castration-Resistant Prostate Cancer. Journal of Nuclear Medicine, 66 (9), 1385 - 1391. doi:10.2967/jnumed.125.269729 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Grandjean, F., Withofs, N., Detrembleur, N., GERARD, L., Lamborelle, P., VALKENBORGH, C., Dardenne, N., & Cousin, F. (02 April 2025). Incidence and features of pulmonary track nodules after CT-guided lung biopsy with track sealing using gelatin sponge slurry. BMC Medical Imaging, 25 (1), 107. doi:10.1186/s12880-025-01644-x Peer Reviewed verified by ORBi |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (11 March 2025). Development of a Single-Domain Antibody-Based Radiopharmaceutical for Targeted Alpha Therapy of Multiple Myeloma [Poster presentation]. European Molecular Imaging Meeting (EMIM), Bilbao, Spain. Editorial reviewed |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Jassin, M., Caers, J., & Bridoux, J. (29 January 2025). CD38-based Targeted Alpha Therapy for the treatment of multiple myeloma [Poster presentation]. Seminaire Télévie, 4000 - Liège, Belgium. Editorial reviewed |
 | Steenhout, C., Deprez, L., Hustinx, R., & Withofs, N. (January 2025). Brain Tumor Assessment: Integrating PET/Computed Tomography and MR Imaging Modalities. PET Clinics, 20 (1), 165 - 174. doi:10.1016/j.cpet.2024.09.003 Peer Reviewed verified by ORBi |
Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Legrand, M., Tutunaru, A.-C., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (19 December 2024). [18F]FAPI-74 PET/CT in dogs with idiopathic pulmonary fibrosis [Paper presentation]. 11th FARAH Day, Liège, Belgium. Peer reviewed |
Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Tutunaru, A.-C., Legrand, M., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (19 November 2024). [18F]FAPI-74 PET/CT in dogs with idiopathic pulmonary fibrosis [Paper presentation]. Veterinary Comparative Respiratory Society Symposium, Levi, Finland. Peer reviewed |
 | Bocuzzi, V., Bridoux, J., PIROTTE, M., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., & Marcion, G. (05 November 2024). CD38 as theranostic target in oncology. Journal of Translational Medicine, 22 (1), 998. doi:10.1186/s12967-024-05768-6 Peer Reviewed verified by ORBi |
 | Stoffels, M., Cousin, F., Lamande, M., Denis, C., Waltregny, D., Hustinx, R., Sautois, B., & Withofs, N. (2024). Characterization of exclusive rib lesions detected by [68Ga]Ga-PSMA-11 PET/CT. Nuclear Medicine Communications. doi:10.1097/MNM.0000000000001919 Peer Reviewed verified by ORBi |
Rizzoli, E., Bahri, M. A., Dammicco, S., Degueldre, C., Legrand, M., Tutunaru, A.-C., Bolen, G., Withofs, N., Gendron, T., & Clercx, C. (12 October 2024). [18F]FAPI-74 PET/CT in dogs with idiopathic pulmonary fibrosis [Poster presentation]. 22nd International Colloquium on Lung and Airway Fibrosis, Athènes, Greece. Peer reviewed |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Caers, J., & Bridoux, J. (10 October 2024). Targeted Alpha Therapy for the treatment of multiple myeloma using CD38-targeting sdAb 2F8 [Poster presentation]. Belgian Association for Cancer Research annual meeting (BACR), Bruxelles, Belgium. Editorial reviewed |
 | Withofs, N., Bonnet, C., & Hustinx, R. (October 2024). 2-deoxy-2-[18F]FDG PET Imaging for Therapy Assessment in Hodgkin's and Non-Hodgkin Lymphomas. PET Clinics, 19 (4), 447 - 462. doi:10.1016/j.cpet.2024.05.001 Peer Reviewed verified by ORBi |
 | Nanni, C., Deroose, C. M., Balogova, S., Lapa, C., Withofs, N., Subesinghe, M., Jamet, B., Zamagni, E., Ippolito, D., Delforge, M., & Kraeber-Bodéré, F. (2024). EANM guidelines on the use of [18F]FDG PET/CT in diagnosis, staging, prognostication, therapy assessment, and restaging of plasma cell disorders. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-024-06858-9 Peer Reviewed verified by ORBi |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Dumoulin, M., Caers, J., & Bridoux, J. (30 May 2024). Targeted Alpha Therapy for the treatment of multiple myeloma using CD38-targeting sdAb 2F8 [Poster presentation]. Interuniversity PhD student day, Louvain-La-Neuve, Belgium. Editorial reviewed |
 | MARCHIORI, S., Cousin, F., Papadopoulos, I., Bernard, C., THYS, M., DE PRIJCK, B., Pirotte, M., Donneau, A.-F., Hustinx, R., Caers, J., & Withofs, N. (28 May 2024). Prognostic value of visual IMPeTUs criteria and metabolic tumor burden at baseline [18F]FDG PET/CT in patients with newly diagnosed multiple myeloma. EJNMMI Research, 14 (1), 51. doi:10.1186/s13550-024-01113-6 Peer Reviewed verified by ORBi |
 | Bocuzzi, V., Marcion, G., Withofs, N., Hustinx, R., D'Huyvetter, M., Navarro, L., Brans, A., Dumoulin, M., Caers, J., & Bridoux, J. (06 February 2024). CD38-based Targeted Alpha Therapy for the treatment of multiple myeloma [Poster presentation]. Congrès Télévie 2024, Bruxelles, Belgium. Editorial reviewed |
 | Bocuzzi, V., Bridoux, J., PIROTTE, M., Withofs, N., Hustinx, R., D'Huyvetter, M., Caers, J., & Marcion, G. (2024). Correction to: CD38 as theranostic target in oncology (Journal of Translational Medicine, (2024), 22, 1, (998), 10.1186/s12967-024-05768-6). Journal of Translational Medicine, 22 (1), 1113. doi:10.1186/s12967-024-05959-1 Peer Reviewed verified by ORBi |
 | LUCIA, F., Withofs, N., Lovinfosse, P., & Hustinx, R. (2024). TEP/TDM en radiothérapie : indications et perspectives. Revue Médicale de Liège. Editorial Reviewed verified by ORBi |
 | Withofs, N. (21 September 2023). LES RADIOTRACEURS AUTRES QUE LE PSMA-LIGAND POUR L’IMAGERIE TEP DU CANCER DE PROSTATE. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 47 (5), 281-290. doi:10.1016/j.mednuc.2023.07.008 |
 | Bocuzzi, V., Duray, E., Caers, J., Dammicco, S., Withofs, N., Tano, H., Westerlund, K., & Eriksson Karlström, A. (18 September 2023). Nanobody 2F8-based PNA-mediated pre-targeting for the treatment of multiple myeloma [Poster presentation]. Single-Domain Antibodies conference, Paris, France. Editorial reviewed |
 | Vandenberghe, S., Muller, F. M., Withofs, N., Dadgar, M., Maebe, J., Vervenne, B., Akl, M. A., Xue, S., Shi, K., Sportelli, G., Belcari, N., Hustinx, R., Vanhove, C., & Karp, J. S. (2023). Walk-through flat panel total-body PET: a patient-centered design for high throughput imaging at lower cost using DOI-capable high-resolution monolithic detectors. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-023-06341-x Peer Reviewed verified by ORBi |
 | Nanni, C., Kobe, C., Baeßler, B., Baues, C., Boellaard, R., Borchmann, P., Buck, A., Buvat, I., Chapuy, B., Cheson, B. D., Chrzan, R., Cottereau, A.-S., Dührsen, U., Eikenes, L., Hutchings, M., Jurczak, W., Kraeber-Bodéré, F., Lopci, E., Luminari, S., ... Kunikowska, J. (May 2023). European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours. The Lancet Haematology, 10 (5), 367 - e381. doi:10.1016/S2352-3026(23)00030-3 Peer Reviewed verified by ORBi |
 | Somja, J., Collins, P., Lampertz, S., Withofs, N., Bisig, B., & de Leval, L. (22 September 2022). Early phase of Angioimmunoblastic T-cell Lymphoma mimicking Marginal Zone Lymphoma [Paper presentation]. 21th Meeting of the European Association for Haematopathology, Florence, Italy. Peer reviewed |
 | WITHOFS, N., Kumar, R., Alavi, A., & HUSTINX, R. (July 2022). Facts and Fictions About [18F]FDG versus Other Tracers in Managing Patients with Brain Tumors: It Is Time to Rectify the Ongoing Misconceptions. PET Clinics, 17 (3), 327-342. doi:10.1016/j.cpet.2022.03.004 Peer Reviewed verified by ORBi |
 | LOVINFOSSE, P., Ferreira, M., WITHOFS, N., JADOUL, A., Derwael, C., Frix, A.-N., GUIOT, J., BERNARD, C., Diep, A. N., Donneau, A.-F., LEJEUNE, M., BONNET, C., Vos, W., Meyer, P., & HUSTINX, R. (19 May 2022). Distinction of lymphoma from sarcoidosis at FDG PET/CT - evaluation of radiomic-feature guided machine learning versus human reader performance. Journal of Nuclear Medicine, 63, 1933-1940. doi:10.2967/jnumed.121.263598 Peer Reviewed verified by ORBi |
 | Denis, C., COUSIN, F., De Laere, B., HUSTINX, R., SAUTOIS, B.* , & WITHOFS, N.*. (21 April 2022). Using, 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer: an application of EAU/EANM recommendations in clinical practice. Journal of Nuclear Medicine, 63 (12), 1815-1821. doi:10.2967/jnumed.121.263611 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Lamaye, C., Bastin, C., BERNARD, C., WITHOFS, N., HUSTINX, R., & SALMON, E. (April 2022). Analyse comparative de la distribution cérébrale du [18F]FDG dans une population de patients souffrant de maladie d’Alzheimer présentant ou non des antécédents familiaux de démence. Revue Médicale de Liège, 77 (4), 224-230. Editorial Reviewed verified by ORBi |
 | Denis, C., Cousin, F., De Laere, B., Hustinx, R., Sautois, B., & Withofs, N. (2022). Using 68Ga-PSMA-11 PET/CT for therapy response assessment in patients with metastatic castration-resistant prostate cancer : an application of EAU/EANM recommendations in clinical practice [Poster presentation]. BMUC, Belgium. Editorial reviewed |
 | Mina, M., JACQUERIE, P., DUQUENNE, J. B., LAVIGNE, J.-P., BOULANGER, Y.-G., BISOGNI, C., Derwael, C., WITHOFS, N., MALAISE, M., & MALAISE, O. (2022). Périostite bilatérale et polyarthrite : à propos d'un cas d'ostéoarthropathie hypertrophique pneumique. Revue Médicale de Liège. Editorial Reviewed verified by ORBi |
 | Caers, J., Duray, E., Vrancken, L., Marcion, G., Bocuzzi, V., De Veirman, K., Krasniqi, A., Lejeune, M., Withofs, N., Devoogdt, N., Dumoulin, M., Karlström, A. E., & D'Huyvetter, M. (2022). Radiotheranostic Agents in Hematological Malignancies. Frontiers in Immunology, 13, 911080. doi:10.3389/fimmu.2022.911080 Peer Reviewed verified by ORBi |
 | Denis, C., Sakalihasan, S., FRERES, P., WITHOFS, N., & SAUTOIS, B. (2021). Cemiplimab for cisplatin resistant metastatic penile cancer. Case Reports in Oncology, 14, 972-976. doi:10.1159/000517008 Peer Reviewed verified by ORBi |
 | WITHOFS, N. (23 October 2020). Use of PET in Multiple Myeloma: Where are we now with Non-FDG [Paper presentation]. 33rd Annual Congress of the European Association of Nuclear Medicine. |
 | Derwael, C., Lavergne, O., LOVINFOSSE, P., Nechifor, V., Salvé, M., Waltregny, D., Hustinx, R., & WITHOFS, N. (2020). Interobserver agreement of [(68)Ga]Ga-PSMA-11 PET/CT images interpretation in men with newly diagnosed prostate cancer. EJNMMI Research, 10 (1), 15. doi:10.1186/s13550-020-0596-4 Peer Reviewed verified by ORBi |
 | CHARLIER, E.* , DEROYER, C.* , NEUVILLE, S., Plener, Z., MALAISE, O., Ciregia, F., Gillet, P., Reuter, G., Salvé, M., Withofs, N., Hustinx, R., de Seny, D.* , & Malaise, M.*. (2020). Toward diagnostic relevance of the α(V)β(5), α(V)β(3), and α(V)β(6) integrins in OA: expression within human cartilage and spinal osteophytes. Bone Research, 8, 35. doi:10.1038/s41413-020-00110-4 Peer Reviewed verified by ORBi* These authors have contributed equally to this work. |
 | Charlier, E., NEUVILLE, S., PLENER, Z., DEROYER, C., RELIC, B., MALAISE, O., REUTER, G., GILLET, P., Salvé, M., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (May 2019). EXPRESSION OF αVβ5, αVβ3 AND β6 INTEGRINS BY OSTEOARTHRITIC CHONDROCYTES AND VERTEBRAL OSTEOPHYTES [Poster presentation]. OARSI, Toronto, Canada. |
 | WITHOFS, N., Beguin, Y., COUSIN, F., Tancredi, T., SIMONI, P., Alvarez-Miezentseva, V., DE PRIJCK, B., HAFRAOUI, K., Bonnet, C., Baron, F., Hustinx, R., & Caers, J. (2019). Dual-tracer PET/CT scan after injection of combined [ 18 F]NaF and [ 18 F]FDG outperforms MRI in the detection of myeloma lesions. Hematological Oncology, 37, 193-201. doi:10.1002/hon.2600 Peer Reviewed verified by ORBi |
 | LOVINFOSSE, P., Ben Mustapha, S., & WITHOFS, N. (2019). Editorial commentary to “18F-Fluorocholine PET uptake correlates with pathologic evidence of recurrent tumor after stereotactic radiosurgery for brain metastases” by Grkovski and colleagues. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-019-04651-7 Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., Duray, E., WITHOFS, N., Bolomsky, A., Baron, F., Beguin, Y., Menu, E., Ludwig, H., & Caers, J. (2018). Molecular mechanisms, current management and next generation therapy in myeloma bone disease. Leukemia and Lymphoma, 59, 14-28. doi:10.1080/10428194.2017.1323272 Peer Reviewed verified by ORBi |
 | MARCHETTA, S., WITHOFS, N., ERBA, P. A., HABIB, G., HUSTINX, R., & LANCELLOTTI, P. (August 2017). RADIONUCLIDE IMAGING OF INFECTIVE ENDOCARDITIS: state of art and future perspective. Current Cardiovascular Imaging Reports, 10 (27). doi:10.1007/s12410-017-9425-1 Peer reviewed |
CHARLIER, E., NEUVILLE, S., RELIC, B., DEROYER, C., MALAISE, O., KURTH, W., GILLET, P., WITHOFS, N., HUSTINX, R., DE SENY, D., & MALAISE, M. (April 2017). Regulation of αVβ3 and αVβ5 integrin complexes by osteogenic differentiation of human hip OA chondrocytes [Poster presentation]. 2017 World Congress on Osteoarthritis. |
Ehx, G., Fransolet, G., de Leval, L., Stéphanie D'Hondt, Sophie Lucas, Guillaume Becker, Withofs, N., Hannon, M., Delens, L., Drion, P., Beguin, Y., Stéphanie Humblet-Baron, & Baron, F. (March 2017). Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects [Paper presentation]. 43rd Annual Meeting of the EBMT, Marseille, France. Peer reviewed |
 | Deleixhe, B., FRIPPIAT, F., Léonard, P., WITHOFS, N., MEEX, C., Pierard, L., & Moutschen, M. (2017). Endocardite à aggregatibacter aphrophilus sur prothèses valvulaires. Revue Médicale de Liège, 72 (12), 522-528. Peer reviewed |
 | WITHOFS, N., COUSIN, F., DE PRIJCK, B., Bonnet, C., Hustinx, R., Gambhir, S. S., Beguin, Y., & Caers, J. (2017). A First Report on [(18)F]FPRGD2 PET/CT Imaging in Multiple Myeloma. Contrast Media and Molecular Imaging, 2017, 6162845. doi:10.1155/2017/6162845 Peer Reviewed verified by ORBi |
 | Hillengass, J., Moulopoulos, L. A., Delorme, S., Koutoulidis, V., Mosebach, J., Hielscher, T., Drake, M., Rajkumar, S. V., Oestergaard, B., Abildgaard, N., Hinge, M., Plesner, T., Suehara, Y., Matsue, K., Waage, A., Goldschmidt, H., Dimopoulos, M. A., Lentzsch, S., Durie, B., ... CAERS, J. (2017). Whole-body computed tomography versus conventional skeletal survey in patients with multiple myeloma: a study of the International Myeloma Working Group. Blood Cancer Journal, 7 (8), 599. doi:10.1038/bcj.2017.78 Peer Reviewed verified by ORBi |
 | Heusschen, R., Muller, J., WITHOFS, N., BARON, F., BEGUIN, Y., & CAERS, J. (2017). Multiple myeloma bone disease: from mechanisms to next generation therapy. Belgian Journal of Hematology, 8, 66-74. Peer Reviewed verified by ORBi |
 | PAQUES, F., HAMOIR, E., LOVINFOSSE, P., HUSTINX, R., & WITHOFS, N. (2016). A case of added value of 123I-mIBG SPECT/CT imaging in the diagnosis of a pheochromocytoma extending into the left adrenal vein. Acta Chirurgica Belgica. doi:10.1080/00015458.2016.1240917 Peer Reviewed verified by ORBi |
 | WITHOFS, N., COUSIN, F., TANCREDI, T., SIMONI, P., DE PRIJCK, B., HAFRAOUI, K., BONNET, C., HUSTINX, R., BEGUIN, Y., & CAERS, J. (14 June 2016). Comparison of combined whole-body 18F-NAF and 18F-FDG PET/CT versus MRI for the detection of myeloma lesions [Paper presentation]. SNMMI 2016 Annual Meeting. |
 | WITHOFS, N., & HUSTINX, R. (19 February 2016). Integrin αvβ3 and RGD-based radiopharmaceuticals. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (2016), 41-54. doi:10.1016/j.mednuc.2015.12.002 Peer Reviewed verified by ORBi |
 | Barrington, S. F., Fosse, P., WITHOFS, N., Itti, E., Hustinx, R., Couturier, O.-F., & Meignan, M. (2016). Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire: Imagerie Fonctionnelle et Métabolique, 40 (1), 55 - 64. doi:10.1016/j.mednuc.2015.12.004 Peer Reviewed verified by ORBi |
 | WITHOFS, N., Martinive, P., VANDERICK, J., BLETARD, N., SCAGNOL, I., Mievis, F., Giacomelli, F., Coucke, P., Delvenne, P., Cataldo, D., Gambhir, S. S., & HUSTINX, R. (2016). [18F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. European Journal of Nuclear Medicine and Molecular Imaging. doi:10.1007/s00259-015-3219-y Peer Reviewed verified by ORBi |
 | NCHIMI LONGANG, A., Courtois, A., EL HACHEMI, M., Touat, Z., Drion, P., WITHOFS, N., Warnock, G., Bahri, M. A., Dogné, J.-M., CHERAMY-BIEN, J.-P., SCHOYSMAN, L., Joskin, J., Michel, J.-B., Defraigne, J.-O., Plenevaux, A., & SAKALIHASAN, N. (2016). Multimodality imaging assessment of the deleterious role of the intraluminal thrombus on the growth of abdominal aortic aneurysm in a rat model. European Radiology, 26, 2378-2386. doi:10.1007/s00330-015-4010-y Peer Reviewed verified by ORBi |
 | WITHOFS, N. (2015). Imaging integrin αvβ3 using [18F]FPRGD2 positron emission tomography combined with computed tomography [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/190692 |
 | WITHOFS, N., NANNI, C., SIMONI, P., FANTI, S., BEGUIN, Y., & CAERS, J. (20 March 2015). Imaging myeloma and related monoclonal plasma cell disorders using MRI, low dose whole-body CT and FDG PET/CT. Clinical and Translational Imaging, 3, 95-109. doi:10.1007/s40336-015-0119-x Peer reviewed |
 | WITHOFS, N., SIGNOLLE, N., SOMJA, J., LOVINFOSSE, P., MUTIJIMA NZARAMBA, E., Mievis, F., Giacomelli, F., WALTREGNY, D., CATALDO, D., GAMBHIR, S. S., & HUSTINX, R. (2015). 18F-FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas: Correlation with histopathology. Journal of Nuclear Medicine. doi:10.2967/jnumed.114.149021 Peer Reviewed verified by ORBi |
 | WITHOFS, N., CHARLIER, E., Simoni, P., Alvarez-Miezentseva, V., Mievis, F., Giacomelli, F., Mella, C., Gambhir, S. S., Malaise, O., DE SENY, D., MALAISE, M., & HUSTINX, R. (2015). (18)F-FPRGD2 PET/CT imaging of musculoskeletal disorders. Annals of Nuclear Medicine, 29 (10), 839-47. doi:10.1007/s12149-015-1011-5 Peer Reviewed verified by ORBi |
 | CAERS, J., WITHOFS, N., Hillengass, J., SIMONI, P., Zamagni, E., HUSTINX, R., & BEGUIN, Y. (April 2014). The role of positron emission tomography-computed tomography and magnetic resonance imaging in diagnosis and follow-up of multiple myeloma. Haematologica, 99 (4), 629-37. doi:10.3324/haematol.2013.091918 Peer Reviewed verified by ORBi |
 | LALLEMAND, F., LAKOSI, F., HUSTINX, R., WITHOFS, N., MEUNIER, P., TSHIBANDA, L., JODOGNE, S., COUCKE, P., & MARTINIVE, P. (2014). Utilisation de l'imagerie fonctionnelle en radiothérapie. Revue Médicale de Liège, 69 (Supp 1), 20-28. Peer reviewed |
 | WITHOFS, N., & HUSTINX, R. (2014). Imagerie de l'intégrine αvβ3 par PET/CT au 18F-FPRGD2. Revue Médicale de Liège, 69 (Synthèse 2014), 36-40. Peer reviewed |
 | SCHENA, A., Ansseau, M., TRIFFAUX, J.-M., Salmon, E., WITHOFS, N., & Scantamburlo, G. (2014). Le cas clinique du mois : Pseudo-démence dépressive. Revue Médicale de Liège, 69 (2), 64-67. Peer reviewed |
 | WITHOFS, N., BERNARD, C., VAN DER REST, C., MARTINIVE, P., HATT, M., JODOGNE, S., VISVIKIS, D., LEE, J. A., COUCKE, P., & HUSTINX, R. (2014). FDG PET/CT for rectal carcinoma radiotherapy treatment planning : Comparison of functional volume delineation algorithms and clinical challenges. Journal of Applied Clinical Medical Physics, 15 (5), 216-228. doi:10.1120/jacmp.v15i5.4696 Peer Reviewed verified by ORBi |
 | WITHOFS, N., ALVAREZ MIEZENTSEVA, V., SIMONI, P., Luxen, A., GAMBHIR, S., & HUSTINX, R. (2013). Imaging osteoarthritis using (18F)FPRGD2 PET/CT : observation and potential application. Journal of Nuclear Medicine, 54 (SUPPL), 250. Peer Reviewed verified by ORBi |
 | SIMONI, P., STULKO, J., BEN MUSTAPHA, S., SCHOYSMAN, L., BIANCHI, E., WITHOFS, N., RACARU, T., CAERS, J., & ALVAREZ MIEZENTSEVA, V. (2013). Bone mass of the calvarium. Skeletal Radiology, 42, 1185-1187. doi:10.1007/s00256-012-1547-6 Peer Reviewed verified by ORBi |
 | WITHOFS, N., SIGNOLLE, N., NZARAMBA, E., THONON, D., LEONARD, M., AERTS, J., WALTREGNY, D., CATALDO, D., GAMBHIR, S., & HUSTINX, R. (2012). (18F)FPRGD2 PET/CT imaging of integrin αvβ3 in renal carcinomas : correlation with histopathology. Journal of Nuclear Medicine, 53 (SUPPL), 1647. Peer Reviewed verified by ORBi |
 | Govaerts, L., WITHOFS, N., DURIEUX, R., Spote, V., & Hustinx, R. (2012). Acute intramural haematoma of the ascending aorta. European Journal of Nuclear Medicine and Molecular Imaging, 39 (8), 1368-9. doi:10.1007/s00259-012-2130-z Peer Reviewed verified by ORBi |
 | WITHOFS, N., MARTINIVE, P., SCAGNOL, I., THONON, D., Giacomelli, F., Mievis, F., COUCKE, P., CATALDO, D., Gambhir, S., & HUSTINX, R. (2012). Preliminary results of (18F)FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma. Journal of Nuclear Medicine, 53 (SUPPL), 1703. Peer Reviewed verified by ORBi |
 | Tran, P. T., Shroff, E. H., Burns, T. F., Thiyagarajan, S., Das, S. T., Zabuawala, T., Chen, J., Cho, Y.-J., Luong, R., Tamayo, P., Salih, T., Aziz, K., Adam, S. J., Vicent, S., Nielsen, C. H., WITHOFS, N., Sweet-Cordero, A., Gambhir, S. S., Rudin, C. M., & Felsher, D. W. (2012). Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genetics, 8 (5), 1002650. doi:10.1371/journal.pgen.1002650 Peer Reviewed verified by ORBi |
 | Withofs, N., Grayet, B., Tancredi, T., Rorive, A., Mella, C., Giacomelli, F., Mievis, F., Aerts, J., Waltregny, D., Jerusalem, G., & Hustinx, R. (2011). 18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers. Nuclear Medicine Communications, 32 (3), 168-176. doi:10.1097/MNM.0b013e3283412ef5 Peer Reviewed verified by ORBi |
 | WITHOFS, N., COLLIGNON, J., RORIVE, A., JERUSALEM, G., & HUSTINX, R. (2011). Hétérogénéité des métastases osseuses du cancer du sein : cas clinique illustrant l'intérêt de combiner différentes techniques d'imagerie. Revue Médicale de Liège, 66 (5-6), 288-290. Peer reviewed |
 | WITHOFS, N., COLLIGNON, J., & HUSTINX, R. (2011). Imagerie des métastases osseuses du cancer du sein. Revue Médicale de Liège, 66 (5-6), 291-298. Peer reviewed |
| WITHOFS, N., Bernard, C., VAN DER REST, C., MARTINIVE, P., HATT, M., Dimitris, V., COUCKE, P., & HUSTINX, R. (2011). FDG PET/CT for radiotherapy treatment planning. Comparison of functional volume delineation algorithms. Journal of Nuclear Medicine. Peer Reviewed verified by ORBi |
 | COUCKE, P., WITHOFS, N., JANSEN, N., JANVARY, Z. L., & HUSTINX, R. (2010). Vers une radiothérapie chirurgicale :nécessité d’une radiothérapie guidée par l’imagerie. Revue Médicale de Liège, 65 (supp 1), 17-22. Peer reviewed |
 | Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2010). Contribution of positron emission tomography in pleural disease. Revue des Maladies Respiratoires, 27 (8), 47-53. doi:10.1016/j.rmr.2009.12.003 Peer Reviewed verified by ORBi |
 | Nielsen, C. H., Kimura, R. H., WITHOFS, N., Tran, P. T., Miao, Z., Cochran, J. R., Cheng, Z., Felsher, D., Kjaer, A., Willmann, J. K., & Gambhir, S. S. (2010). PET imaging of tumor neovascularization in a transgenic mouse model with a novel 64Cu-DOTA-knottin peptide. Cancer Research, 70 (22), 9022-30. doi:10.1158/0008-5472.CAN-10-1338 Peer Reviewed verified by ORBi |
 | Jerusalem, G., & Withofs, N. (2009). Nuclear medicine imaging. In H.-J. Schmoll, L. Van't Veer, J. Vermorken, ... D. Schrijvers (Eds.), ESMO Handbook of Cancer Diagnosis and Treatment Evaluation (pp. 29-36). Informa Healthcare. |
 | Duysinx, B., Corhay, J.-L., Larock, M.-P., Withofs, N., Bury, T., Hustinx, R., & Louis, R. (2008). Apport de l'imagerie par tomographie a emission de positons dans la pathologie pleurale. Interet de la TEP en pathologie pleurale. Revue des Maladies Respiratoires, 25 (2), 129-38. doi:10.1016/S0761-8425(08)71511-0 Peer Reviewed verified by ORBi |
 | WITHOFS, N., GRAYET, B., Tancredi, T., RORIVE, A., BECKERS, C., JERUSALEM, G., & HUSTINX, R. (2008). PET/CT for assessing bone involvement in prostate and breast cancer. Journal of Nuclear Medicine, 49 (SUPPL), 21. Peer Reviewed verified by ORBi |
RUTTEN, I., CABAY, J.-E., WITHOFS, N., LEMAIRE, C., AERTS, J., BAART, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 1-18F-fluoro-L-tyrosine; initial report. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE. Peer reviewed |
 | Withofs, N., Salmon, E., Hallet, C., Desfontaines, P., Laureys, S., Moonen, G., & Hustinx, R. (May 2007). Effect of dementia severity and age on posterior cingulate cortex metabolism in Alzheimer's disease. Journal of Neurology, 254 (Suppl. 3), 146. Peer Reviewed verified by ORBi |
 | Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & Hustinx, R. (May 2007). PET/CT of skull base meningiomas using 2-F-18-fluoro-L-tyrosine: Initial report. Journal of Nuclear Medicine, 48 (5), 720-725. doi:10.2967/jnumed.106.038216 Peer Reviewed verified by ORBi |
MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Another etiology for inflammatory syndrome of unknown origin. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE. Peer reviewed |
MEDART, L., WITHOFS, N., HUSTINX, R., & DONDELINGER, R. (2007). Gossypiboma at PET-CT. In PROCEEDINGS OF XIIIth SYMPOSIUM OF THE BELGIAN SOCIETY OF NUCLEAR MEDICINE. Peer reviewed |
 | Jerusalem, G., Withofs, N., Rorive, A., & Hustinx, R. (2007). Tomographie a emission de positons: un premier bilan. Revue du Praticien, 57 (17), 1864-70. Peer reviewed |
 | WITHOFS, N., SALMON, E., LAUREYS, S., DESFONTAINES, P., & HUSTINX, R. (2007). Voxel-based analysis of dementia severity versus age on cerebral metabolic dysfunction in Alzheimer’s disease. Journal of Nuclear Medicine, 48 (SUPPL), 172. Peer Reviewed verified by ORBi |
 | Rutten, I., Cabay, J.-E., Withofs, N., Lemaire, C., Aerts, J., Baart, V., & HUSTINX, R. (2007). PET/CT imaging of skull base meningiomas using 2-18F-fluoro-L-tyrosine : Initial report. Journal of Nuclear Medicine, 48 (SUPPL), 11. Peer Reviewed verified by ORBi |
Massin, M., Withofs, N., & Ravet, F. (April 2002). Heart rate variability in infants with obstructive sleep apnea. Archives de Pédiatrie, 9 (4), 444-445. doi:10.1016/S0929-693X(01)00808-9 |
 | Massin, M., Withofs, N., Maeyns, K., Ravet, F., & Gérard, P. (November 2001). Normal ranges for the variability in heart rate in young infants while sleeping. Cardiology in the Young, 11 (6), 619-625. doi:10.1017/S104795110100097X Peer Reviewed verified by ORBi |
 | Massin, M. M., Withofs, N., Maeyns, K., & Ravet, F. (2001). The Influence of Fetal and Postnatal Growth on Heart Rate Variability in Young Infants. Cardiology, 95 (2), 80-3. doi:10.1159/000047350 Peer Reviewed verified by ORBi |
 | Massin, M. M., Maeyns, K., Withofs, N., Ravet, F., & Gérard, P. (August 2000). Circadian Rhythm of Heart Rate and Heart Rate Variability. Archives of Disease in Childhood, 83 (2), 179-82. doi:10.1136/adc.83.2.179 Peer Reviewed verified by ORBi |
 | Massin, M. M., Maeyns, K., Withofs, N., & Gérard, P. (2000). Dependency of Premature Ventricular Contractions on Heart Rate and Circadian Rhythms During Childhood. Cardiology, 93 (1-2), 70-3. doi:10.1159/000007004 Peer Reviewed verified by ORBi |
